NACL Ind. RI review - (Not Rated)

•    The company is engaged in manufacturing technical agrochemicals and formulations.
•    It has many alarms in the form of natural calamity, government policies, market trends for crop, water scarcity etc., perhaps due to this, it posted losses for FY24, FY25.
•    This RI is at a discount of around 100.46% based on its last traded price.
•    The RI is at an appealing and attractively priced.
•    Based on its recent financial data, the RI appears aggressively priced.
•    Well-informed investors may park funds for medium to long term.

ABOUT COMPANY:
NACL Industries Ltd. (NIL) erstwhile known as Nagarjuna Agrichem Ltd., is engaged in the manufacture of agrochemical Technicals (active ingredients) and Formulations, and as a result, its business is sensitive to weather conditions such as drought, floods, cyclones, force majeure and natural disasters, as well as events such as pest infestations. The weather can affect the presence of disease and pest infestations in the short term on a regional basis, and accordingly, may adversely affect demand for crop protection products.

Its results of operations are significantly affected by weather conditions in the agricultural regions in which products are used. The most important determinant of its sales is the volume of crops planted each season. Adverse conditions early in the season, especially drought conditions, can result in significantly lower than normal plantings of crops and therefore lower demand for crop protection products. This can result in its sales in a particular region varying substantially from year to year. Weather conditions can also result in earlier or later plantings and affect the levels of pest infestations, which may affect both the timing and volume of its sales or the product mix. Adverse weather conditions may also cause volatility in the prices of commodities, which may affect farmers’ decisions about the types and quantum of crops to plant and may consequently affect the sales of its agrochemical Technicals and Formulations. Further, the company may be subjected to decreased availability of water, which could impact manufacturing operations. The increasing concern over climate change may also result in enhanced regional and global legal and regulatory requirements to reduce or mitigate the effects of greenhouse gases, as well as more stringent regulation of water rights. In the event that such regulations are enacted and are more aggressive than the sustainability measures that NIL is currently undertaking to monitor emissions, improve its energy efficiency, and reduce and reuse water, it may experience significant increases in costs of operations.

Further, the sales of agrochemical products are seasonal due to monsoon with the demand for pesticides generally higher during the monsoon season in India and other jurisdictions where its products are exported. Lack of monsoon in a particular year may result in a decline in demand for products. As a result of such seasonal fluctuations, its sales and results of operations may vary by fiscal quarter and may not be relied upon as indicators of the sales or results of operations of other fiscal quarters, or of future performance. Any significant reduction in the area under cultivation for these crops may significantly reduce demand for products. Further, the demand for products depends on the cropping pattern, which may vary year on year for these major crops. Any significant changes in the cultivable area and the cropping pattern for these crops may impact its sales and profitability.

The manufacturing units of NIL are located in the state of Andhra Pradesh. Any materially adverse social, political or economic development, natural calamities, civil disruptions, or changes in the policies of the state government or local governments in these regions could adversely affect manufacturing operations and require a modification of its business strategy, or require to incur significant capital expenditure or suspend operations. Any such adverse development affecting continuing operations at the manufacturing facilities of the Company could result in significant loss due to an inability to meet customer requirements and production schedules, which could materially affect business reputation within the industry. The occurrence of, or its inability to effectively respond to, any such events or effectively manage the competition in the region, could have an adverse effect on business, results of operations, financial condition, cash flows and future business prospects. As of September 30, 2025, it had 950 employees on its payroll.

ISSUE DETAILS:
The company is coming out with its Rights Issue (RI) of 32501851 equity shares of Re. 1 each at a fixed price of Rs. 76.70 per share to mobilize Rs. 249.29 cr. The RI opens for subscription on December 22, 2025, and will close on December 30, 2025. The company is offering RI in the ratio of 5 for 31 to its eligible stakeholders as of the record date of December 12, 2025. The company is asking for full money on application for the number of shares applied. Post allotment, RI shares will be listed on BSE and NSE. The company is spending Rs. 1.58 cr. for this RI process, and from the net proceeds, it will utilize Rs. 104.00 cr. for repayment/prepayment of certain outstanding borrowings, Rs. 83.00 cr. for   investment in its subsidiary – NACL Space-Chem Ltd., and Rs. 60.71 cr. for general corporate purposes. 

The RI is solely lead managed by the company itself., and KFin Technologies Ltd. is the registrar to the issue. Fedex Securities Pvt. Ltd. is the advisor to the issue. XL Softech Systems Ltd. is the RTA to the company.

Post-RI, company’s current paid-up equity capital of Rs. 20.15 cr. will stand enhanced to Rs. 23.40 cr. Based on the RI pricing, the company is looking for a market cap of Rs. 1794.88 cr. 

FINANCIAL PERFORMANCE:
On the financial performance front, for the last two fiscals, the company has (on a consolidated basis) posted total revenue / net profit/ - (loss), of Rs. 1787.29 cr. / Rs. – (58.89) cr. (FY24), Rs. 1242.56 cr. / Rs. – (92.13) cr. (FY25). For H1 of FY26 ended on September 30, 2025, it posted a net profit of Rs.15.59 cr. on a total revenue of Rs. 906.43 cr. Its NAV stood at Rs. 22.03 as of September 30, 2025. 

DIVIDEND POLICY:
As per BSE Website, the company has paid a dividend of 0.40 per share in 2023, and 0.45 per share in 2022. It will adopt a prudent dividend policy, based on its financial performance and future prospects. The offer document is silent on its dividend policy.

SCRIP PERFORMANCE: BASED ON BSE WEBSITE DATA: SCRIP CODE: 524709 (FV Re. 1).
The scrip last closed on cum-right basis at Rs. 192.85 on December 11, 2025, and opened on an ex-right basis at Rs. 170.05 on December 12, 2025. Since then, it has marked a high/low of Rs. 179.40 / Rs. 150.15. The scrip last closed at Rs. 153.75 as of December 19, 2025. For the last 52 weeks’ it has posted a high/low of Rs. 309.29 / Rs. 49.46. The counter is currently under ASM LT: Stage 4.

The promoters’ holding declined to 53.09% as of September 30, 2025, against 63.08% as of June 30, 2025.  The counter is trading above the RI price, with well managed volume by the vested interest quarters.

Conclusion / Investment Strategy

NIL is engaged in manufacturing technical agrochemicals and formulations. It has many alarms in the form of natural calamity, government policies, market trends for crop, water scarcity etc., perhaps due to this, it posted losses for FY24, FY25. However, it has turned the corner for H1-FY26. This RI is at a discount of around 100.46% based on its last traded price. The RI is at an appealing and attractively priced. Based on its recent financial data, the RI appears aggressively priced. Well-informed investors may park funds for medium to long term.

Review By Dilip Davda on December 22, 2025

Review Author

Dilip Davda, SEBI Registered Research Analyst

Dilip Davda is a veteran financial journalist associated with the Indian stock market since 1978. He has been contributing to print and electronic media on capital markets, insurance, and finance since 1985.

He is widely recognized for reviewing public issues and non-convertible debentures (NCDs) in the primary market. Drawing on over three decades of market experience and close interaction with merchant bankers, his reviews focus on detailed fundamental and financial analysis of companies, with a special emphasis on SME public issues.

Dilip Davda

SEBI Registered Research Analyst – Mumbai

Registration No.: INH000003127 (Perpetual)

Email: dilip_davda@rediffmail.com


Disclaimer: The information provided herein is solely for educational and informational purposes and does not constitute an offer, solicitation, or recommendation to buy or sell any securities. Readers are advised to consult a qualified financial advisor before making any investment decisions. Investments in the securities market are subject to market risks. The author does not intend to invest in the securities discussed.